Imperial Recognized as 2026 National Best and Brightest Company to Work For! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Ancillary Clinical Trial Supplies and Equipment Clinical Trial Business Insights

Beyond Logistics: Clinical Trial Supply & Equipment Risk Management

by Kristi Killman November 10, 2026
Ancillary Clinical Trial Supplies and Equipment Clinical Trial Materials Development and Printing

Clinical Trial Startup Challenges: What’s Lurking Around the Corner?

by Dan McDonald October 29, 2026
Clinical Trial Business Insights

The Rhythm of a Year

by Brandon Bissell October 27, 2026
Ancillary Clinical Trial Supplies and Equipment Clinical Trial Business Insights

GCSG European Knowledge Forum: More Than Just Another Conference

by Imogen Cheese October 22, 2026
Ancillary Clinical Trial Supplies and Equipment

Building Flexibility Into Clinical Trial Equipment Planning

by Ted Corrigan October 6, 2026
Clinical Trial Materials Development and Printing Participant Engagement

Just-in-Time Printing for Clinical Trials: A Smarter Approach

by Karlton Gray September 21, 2026
Clinical Trial Materials Development and Printing Participant Engagement Translation of Clinical Trial Materials

3 Steps to Create User-Friendly Participant Materials

by Marta Korgol September 9, 2026
Clinical Trial Business Insights

Rethinking Diversity Through Inclusive Clinical Trial Design

by Vaughn X. Anthony September 2, 2026
Clinical Trial Business Insights Clinical Trial Materials Development and Printing Translation of Clinical Trial Materials

How Version Control in Clinical Trial Materials Reduces Risk

by Heather Ross August 26, 2026
Ancillary Clinical Trial Supplies and Equipment

Why Ancillary Supplies Are Rarely Ancillary in Clinical Trials

by Imogen Cheese August 4, 2026
  • Study & Site Print Materials

  • Ancillary Trial Supplies

  • Translation Services

  • Trial Patient Engagement

    Participant Engagement

    The Facts on Patient Enrollment Delays

    by Dan McDonald March 2, 2017
    written by Dan McDonald

    The Undeniable Truth
    Everyone is aware that patient enrollment is an issue. In a recent report from Tufts Center for the Study of Drug Development on 150 global trials, it was discovered that 9 out of 10 studies eventually achieved enrollment goals, but that it can take up to double the original enrollment timeframe to do so.

    The report also found that:
    • 11% of sites failed to enroll a single patient
    • 37% under-enrolled
    • 39% met enrollment targets
    • 13% exceeded their targets

    You cannot deny the existence of significant enrollment concerns. As an industry, we need to do a better job at preparing sites up front to meet their objectives in order to keep studies on track and deliver potentially life-saving drugs to patients.

    Enrollment Delays around the World
    In almost every region around the world, it is normal to see enrollment delays of at least a month or more. Despite dedicated efforts by countless agencies and regulations across the globe, there is no poster child for solving the enrollment plague. With the recent globalization of clinical research, enrollment challenges are no longer contained to a few countries. This is a global issue.

     

    blog

     

    The Bottom Line
    From the Tufts report, we can conclude that nearly 50% of sites do not achieve their enrollment targets. This fact is startling, considering the record-high cost of executing a clinical trial today. In addition to the fixed costs associated with reactionary revival strategies, failure of sites to meet enrollment targets results in immeasurable opportunity costs as well.

    Depending on the type of compound being developed, every day lost can mean tens of thousands up to a million dollars in additional expenses and lost revenue.
    The objective of our new ebook is to help you avoid these costly delays and get your drug to market. You can grab your copy here.

    March 2, 2017 0 comments
    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsParticipant Engagement

    Behind the Scenes at Trial Sponsor Companies Part 2: Enrollment Plans, Strategies, and Metrics

    by Dan McDonald October 19, 2016
    by Dan McDonald October 19, 2016

    In my last blog post, I wrote about findings from a first-of-its kind survey conducted by Imperial. We surveyed managers and directors of clinical operations, project managers, lead/senior CRAs, and patient recruitment specialists from sponsor companies, and ended up with a behind the scenes look …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsParticipant Engagement

    Behind the Scenes at Trial Sponsor Companies Part 1: The Atmosphere in Clinical Operations

    by Dan McDonald October 19, 2016
    by Dan McDonald October 19, 2016

    Patient recruitment and enrollment are key contributors to delays in completion of clinical research trials. How do sponsors tackle their patient recruitment challenges? What priority are these challenges given internally? Imperial wanted to find out. We surveyed 160 line managers in clinical operations at sponsor …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    ESMO 2016: My Perspective as a Patient Advocate

    by Imogen Cheese October 13, 2016
    by Imogen Cheese October 13, 2016

    The ESMO, European Society for Medical Oncologists, annual conference took place in Copenhagen over an extended weekend. I was fortunate to attend as a patient advocate which was quite an honor. There were over 20,000 delegates in attendance and just 150 European patients. Imperial CRS …

    0 FacebookTwitterLinkedinEmail
  • Participant Engagement

    Listening to Our Audience: How Can We Spread the Word About Clinical Trials?

    by Melynda Geurts September 9, 2016
    by Melynda Geurts September 9, 2016

    This is the second of two posts containing excerpts from our just-released ebook on proactive recruitment planning How do patients and caregivers gather information and make decisions about health care? This is an important question, because by identifying the most popular information channels, we can determine how best …

    0 FacebookTwitterLinkedinEmail
Load More Posts

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email Rss

Popular Posts

  • 1

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 2

    See Do Get

    August 12, 2014
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    The Upcoming FDA Clinical Trial Diversity Mandate: What You Need to Know

    May 14, 2025

Categories

  • Ancillary Clinical Trial Supplies and Equipment (44)
  • Clinical Trial Business Insights (198)
  • Clinical Trial Materials Development and Printing (55)
  • Participant Engagement (113)
  • Translation of Clinical Trial Materials (21)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribetoourblogandgetthelatestupdates,insights,andindustrytrendsdeliveredstraighttoyourinbox.Stayinformedandnevermissapost.

 

 


Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace